Biological maturation and β-adrenergic effectors: development of β-adrenergic receptors in rabbit heart
The β-adrenergic receptor, transduction processes and catalytic activity of the adenylate cyclase enzyme complex have been investigated in rabbit heart at different stages of biological maturation. The binding of [3H]-dihydroalprenolol to a washed membrane preparation isolated from rabbit ventricular muscle was used to characterize β-adrenergic receptors. Significant age-related differences were noted in β-receptor affinity (Kd) and density (RD) of neonatal and adult animals; the adult Kd was 3.7-fold greater and the RD 2-fold higher than the neonates. No significant differences in these parameters were detected among the 27-day old fetus and the 1- and 7-day old neonates. Age-dependent differences in agonist isoproterenol affinity for the receptor were not observed in contrast to the significant changes in antagonist (DHA) affinity.
Age-related changes in receptor affinity were also quantitated by determining the inhibitory potency of alprenolol on isoproterenol stimulated adenylate cyclase enzyme activity. A decreased affinity of the β-adrenergic receptor for alprenolol in the adult heart was indicated by a 3.7-fold greater Ki for the adult than the 1-day old neonate. Ontogenic variations in the coupling efficiency between the receptor and catalytic components of the adenylate cyclase complex were also evaluated. The Kd of the β-adrenergic receptor for isoproterenol and the EC50 for adenylate cyclase stimulation were determined under similar conditions. The corresponding coupling index (Kd/ EC50) was found to be 2.4-fold greater in the 1-day old neonate than adult, suggesting that for a given percentage increase in adenylate cyclase activity, a lower percentage of β-adrenergic receptor sites need be occupied in the neonate. These data extend previous studies (29) and indicate all components of the rabbit heart adenylate cyclase enzyme complex (i.e., the β-adrenergic receptor, the GTP-dependent transduction event, and the catalytic subunit) exhibit significant developmental changes.
KeywordsManifold Leukemia Adenosine Norepinephrine Polystyrene
Unable to display preview. Download preview PDF.
- 14.Kaumann, A. J. and Birnbaumer, L., 1973. Acta Phys. Lat. Amer. 23: 619–620.Google Scholar
- 28.Schild, H. O., 1947. J. Pharmacol. 2: 189–206.Google Scholar
- 30.Slotkin, T. A., Smith, P. G., Lau, C. and Bareis, D. L., 1980. In: Biogenic Amines in Development (Parves, S. and Parves, H. eds.), Elsevier, North Holland, Amsterdam.Google Scholar
- 32.W hitsett, J. A. and Darovec-Beckerman, L., 1981. Ped. Res. 15: 1363–1369.Google Scholar